NCT03705091

Brief Summary

Renal transplantation is the optimal method of treatment for end stage kidney disease however median lifespan of a kidney transplant is around 15 years. Existing methods of measuring transplant function and structure from blood and urine markers are imperfect; renal biopsy is often performed but is invasive. Novel methods of investigating transplant function are therefore required and emerging renal MRI sequences including ASL and diffusion weighted imaging may yield helpful biomarkers. Investigators will recruit 20 patients in the first year after transplant and measure MRI biomarkers at three time points, with correlation to existing methods of measuring transplant function.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Apr 2017

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 11, 2017

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

March 3, 2018

Completed
8 months until next milestone

First Posted

Study publicly available on registry

October 15, 2018

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 20, 2019

Completed
28 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 20, 2019

Completed
Last Updated

October 15, 2018

Status Verified

February 1, 2018

Enrollment Period

1.9 years

First QC Date

March 3, 2018

Last Update Submit

October 12, 2018

Conditions

Keywords

Magnetic resonance imagingBiomarkersArterial spin labellingDiffusion weighted imagingRenal transplantation

Outcome Measures

Primary Outcomes (1)

  • Change in arterial spin labelling (ASL)

    Renal perfusion measured by ASL MRI

    Measured at 2, 6, 12 months after transplant

Secondary Outcomes (1)

  • Change in apparent diffusion coefficient (ADC)

    Measured at 2, 6, 12 months after transplant

Study Arms (1)

Transplant

Incident patients receiving a kidney transplant for end stage kidney disease. Patients will undergo functional magnetic resonance imaging at 2 months, 6 months and 12 months following transplantation.

Diagnostic Test: Magnetic resonance imaging

Interventions

ASL and DWI MRI

Transplant

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients who have either recently received, or are undergoing assessment for kidney transplantation, will be recruited. Those receiving live donor transplants undergo surgery electively and can be approached prior to the time of transplant. Those receiving kidney transplants from the waiting list represent the majority of transplant patients, and undergo surgery at unpredictable time points depending on the availability of organs. These individuals will be approached shortly after transplantation. They will be identified from the electronic medical record and approached at the transplant assessment clinic or on the transplant ward. A participant information sheet will be given and the patient contacted after one week to confirm or refute participation.

You may qualify if:

  • Age \> 18 years
  • Recent or pending kidney transplantation
  • Written informed consent

You may not qualify if:

  • Severe chronic liver, heart or lung disease
  • Chronic infection
  • Unable to give valid informed consent
  • Known pregnancy or intent to conceive during the study period
  • Any contraindicating to MRI

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Glasgow

Glasgow, Renfrewshire, G12 8TA, United Kingdom

RECRUITING

MeSH Terms

Conditions

Kidney Failure, ChronicRejection, PsychologyRenal Insufficiency, Chronic

Interventions

Magnetic Resonance Imaging

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsSocial BehaviorBehavior

Intervention Hierarchy (Ancestors)

TomographyDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Central Study Contacts

Keith Gillis, MBChB PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 3, 2018

First Posted

October 15, 2018

Study Start

April 11, 2017

Primary Completion

February 20, 2019

Study Completion

March 20, 2019

Last Updated

October 15, 2018

Record last verified: 2018-02

Locations